S 2554 New Jersey Senate · 2024-2025 Regular Session

Requires SHBP, SEHBP, Medicaid, and NJ FamilyCare to cover anti-obesity medications.

This bill requires New Jersey's State Health Benefits Program (SHBP), School Employees Health Benefits Program (SEHBP), Medicaid, and NJ FamilyCare to cover FDA-approved anti-obesity medications for eligible participants. It mandates coverage when an individual has a diagnosed obesity or obesity-related condition, receives a prescription from a licensed provider, and obtains the medication from an approved pharmacy. The coverage applies to all specified programs, though Medicaid/NJ FamilyCare implementation depends on securing federal approval for waivers. The law aims to expand access to weight management medications for residents with obesity-related health needs.
Bill status in committee 1 of 4 stages cleared
Introduction
Feb 2024
Committee Review
Floor Vote
Governor
Introduced Feb 8, 2024 Last action Feb 8, 2024
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
1
Key actions
0
Committee
0
Feb 8, 2024
Introduced
Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
upper
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of Joe Vitale
Joe Vitale
DDemocratic
NJ
19